These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30733835)

  • 1. Visuoperceptual Impairment in Children with NF1: From Early Visual Processing to Procedural Strategies.
    Bulgheroni S; Taddei M; Saletti V; Esposito S; Micheli R; Riva D
    Behav Neurol; 2019; 2019():7146168. PubMed ID: 30733835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visuoperceptual processing in children with neurofibromatosis type 1: True deficit or artefact?
    Van Eylen L; Plasschaert E; Wagemans J; Boets B; Legius E; Steyaert J; Noens I
    Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):342-358. PubMed ID: 28512747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological factors associated with performance on the rey-osterrieth complex figure test in children with neurofibromatosis type 1.
    Maier A; Pride NA; Hearps SJC; Shah N; Porter M; North KN; Payne JM
    Child Neuropsychol; 2024 Feb; 30(2):348-359. PubMed ID: 37038321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining Rey Complex Figure Test organization in healthy adults.
    Wilson NA; Batchelor J
    J Clin Exp Neuropsychol; 2015; 37(10):1052-61. PubMed ID: 26325340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
    Payne JM; Arnold SS; Pride NA; North KN
    Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Rey Complex Figure copy performance measure executive function in children?
    Weber RC; Riccio CA; Cohen MJ
    Appl Neuropsychol Child; 2013; 2(1):6-12. PubMed ID: 23427771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct attentional and executive profiles in neurofibromatosis type 1: Is there difference with primary attention deficit-hyperactivity disorder?
    Routier L; Querné L; Fontaine C; Berquin P; Le Moing AG
    Eur J Paediatr Neurol; 2024 Jul; 51():93-99. PubMed ID: 38905883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings.
    Erdoğan-Bakar E; Cinbiş M; Ozyürek H; Kiriş N; Altunbaşak S; Anlar B
    Turk J Pediatr; 2009; 51(6):565-71. PubMed ID: 20196390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary study of the different memory systems in neurofibromatosis type 1: What is impaired and what is spared?
    Maziero S; Jucla M; Blais M; Albaret JM; Tallet J; Chaix Y
    Brain Dev; 2023 Apr; 45(4):220-230. PubMed ID: 36609051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1.
    Ribeiro MJ; Violante IR; Bernardino I; Edden RA; Castelo-Branco M
    Cortex; 2015 Mar; 64():194-208. PubMed ID: 25437375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do children with and without autism spectrum disorder use different visuospatial processing skills to perform the Rey-Osterrieth complex figure test?
    Cardillo R; Lievore R; Mammarella IC
    Autism Res; 2022 Jul; 15(7):1311-1323. PubMed ID: 35384343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underlying mechanisms of writing difficulties among children with neurofibromatosis type 1.
    Gilboa Y; Josman N; Fattal-Valevski A; Toledano-Alhadef H; Rosenblum S
    Res Dev Disabil; 2014 Jun; 35(6):1310-6. PubMed ID: 24691356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cognitive profile of preschool-aged children with neurofibromatosis type 1.
    Sangster J; Shores EA; Watt S; North KN
    Child Neuropsychol; 2011; 17(1):1-16. PubMed ID: 20503125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imaging.
    Eby NS; Griffith JL; Gutmann DH; Morris SM
    Dev Med Child Neurol; 2019 Aug; 61(8):972-978. PubMed ID: 30659594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive dysfunction in children with neurofibromatosis type 1: a study of action planning.
    Roy A; Roulin JL; Charbonnier V; Allain P; Fasotti L; Barbarot S; Stalder JF; Terrien A; Le Gall D
    J Int Neuropsychol Soc; 2010 Nov; 16(6):1056-63. PubMed ID: 20682087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The strengths and weaknesses in verbal short-term memory and visual working memory in children with hearing impairment and additional language learning difficulties.
    Willis S; Goldbart J; Stansfield J
    Int J Pediatr Otorhinolaryngol; 2014 Jul; 78(7):1107-14. PubMed ID: 24803399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The handwriting performance of children with NF1.
    Gilboa Y; Josman N; Fattal-Valevski A; Toledano-Alhadef H; Rosenblum S
    Res Dev Disabil; 2010; 31(4):929-35. PubMed ID: 20392595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
    Lorenzo J; Barton B; Arnold SS; North KN
    J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.